These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 6104347)

  • 1. The effects of prostacyclin on glycemia and insulin release in man.
    Szczeklik A; Pietoń R; Sieradzki J; Nizankowski R
    Prostaglandins; 1980 Jun; 19(6):959-68. PubMed ID: 6104347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prostacyclin in treatment of peripheral vascular disease of lower extremities (author's transl)].
    Szczeklik A; Głusko P; Gryglewski R; Szczeklik J; Kostka-Trabka E; Grodzińska L; Nizanowski R; Dembińska-Kieć A; Skawiński S; Bieroń K; Billewicz O; Telesz E
    Przegl Lek; 1980; 37(9):659-62. PubMed ID: 6106960
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostacyclin therapy in peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Skawiński S; Głuszko P; Korbut R
    Thromb Res; 1980 Jul 1-15; 19(1-2):191-9. PubMed ID: 6108623
    [No Abstract]   [Full Text] [Related]  

  • 4. Prostacyclin does not affect insulin secretion in humans.
    Patrono C; Pugliese F; Ciabattoni G; Di Blasi S; Pierucci A; Cinotti GA; Maseri A; Chierchia S
    Prostaglandins; 1981 Mar; 21(3):379-85. PubMed ID: 7015416
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased platelet activity after termination of prostacyclin infusion into man.
    Dembinska-Kiec A; Zmuda A; Grodzinska L; Bieron K; Basista M; Kedzior A; Kostka-Trabka E; Telesz E; Zelazny T
    Prostaglandins; 1981 May; 21(5):827-32. PubMed ID: 6803307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostacyclin and blood glucose levels in humans and rabbits.
    Dembińska-Kieć A; Kostka-Trabka E; Grodzińska L; Zmuda A; Bieroń K; Kedzior A; Ochmański W; Zelazny T
    Prostaglandins; 1981 Jan; 21(1):113-21. PubMed ID: 7010454
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prostacyclin in the therapy of peripheral arterial disease.
    Szczeklik A; Gryglewski RJ; Nizankowski R; Szczeklik J; Skawiński S; Głuszko P
    Adv Prostaglandin Thromboxane Res; 1980; 7():687-9. PubMed ID: 6989195
    [No Abstract]   [Full Text] [Related]  

  • 8. Prostacyclin and vascular disease.
    Gryglewski RJ; Szczeklik A; Zygulska-Mach H; Kostka-Trabka E
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):383-8. PubMed ID: 6117899
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Decreased sensitivity of human platelets to PGI2 during long-term intraarterial prostacyclin infusion in patients with peripheral vascular disease--a rebound phenomenon?
    Sinzinger H; Silberbauer K; Horsch AK; Gall A
    Prostaglandins; 1981 Jan; 21(1):49-51. PubMed ID: 7010457
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Possibilities for clinical use of prostacyclin in vascular disease.
    Poredos P
    Pflugers Arch; 2000; 440(5 Suppl):R137-8. PubMed ID: 11005643
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vascular prostacyclin release and metabolic derangement in diabetes.
    Harrison HE; Johnson M
    Horm Metab Res Suppl; 1981; 11():43-9. PubMed ID: 7033096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of insulin or tolbutamide treatment on 14C-arachidonic acid conversion to prostacyclin and/or thromboxane in lungs, aortas, and platelets of streptozotocin-induced diabetic rats.
    Valentovic MA; Lubawy WC
    Diabetes; 1983 Sep; 32(9):846-51. PubMed ID: 6354792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical potential of prostacyclin.
    Vane JR
    Adv Prostaglandin Thromboxane Leukot Res; 1983; 11():449-56. PubMed ID: 6221561
    [No Abstract]   [Full Text] [Related]  

  • 14. Differential effects of tolbutamide on first and second phase insulin secretion in noninsulin-dependent diabetes mellitus.
    Pfeifer MA; Halter JB; Beard JC; Porte D
    J Clin Endocrinol Metab; 1981 Dec; 53(6):1256-62. PubMed ID: 7028776
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Prostacyclin].
    MMW Munch Med Wochenschr; 1979 Aug; 121(35):1098. PubMed ID: 114771
    [No Abstract]   [Full Text] [Related]  

  • 16. Prostacyclin (PGI2).
    Davies SC; Machin SJ
    Intensive Care Med; 1983; 9(2):49-52. PubMed ID: 6343445
    [No Abstract]   [Full Text] [Related]  

  • 17. Salvage of the severely ischaemic limb by intra-arterial prostacyclin (PGI2) infusion. A case report.
    Søreide O; Segadal L; Trippestad A; Engedal H
    Scand J Thorac Cardiovasc Surg; 1982; 16(1):71-3. PubMed ID: 7041251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Successful therapy of advanced arteriosclerosis obliterans with prostacyclin.
    Szczeklik A; Nizankowski R; Skawinski S; Szczeklik J; Gluszko P; Gryglewski RJ
    Lancet; 1979 May; 1(8126):1111-4. PubMed ID: 86835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The stimulatory effect on insulin secretion in long-term tolbutamide treatment. Immunological determinations of urinary- and serum insulin.
    Johansen K; Orskov H
    Acta Endocrinol (Copenh); 1972 Dec; 71(4):709-15. PubMed ID: 4678208
    [No Abstract]   [Full Text] [Related]  

  • 20. Haemodynamic changes induced by prostacyclin in man.
    Szczeklik J; Szczeklik A; Nizankowski R
    Br Heart J; 1980 Sep; 44(3):254-8. PubMed ID: 7000101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.